A randomized, double-blind, placebo-controlled, Phase I/II trial of RNActive(®)-vaccine cv9104 in patients with metastatic castrate-refractory prostate cancer (mcrpc): first results of the Phase I part

Detalles Bibliográficos
Autores principales: Koch, Sven D, Hong, Henoch, Feyerabend, Susan, Retz, Margitta, Kuebler, Hubert, Heidenreich, Axel, van Erps, Thomas, Schroeder, Andreas, Scheel, Birgit, Reus, Valérie, Kallen, Karl-Josef, Fotin-Mleczek, Mariola, Gnad-Vogt, Ulrike, Stenzl, Arnulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288759/
http://dx.doi.org/10.1186/2051-1426-2-S3-P85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288759/
http://dx.doi.org/10.1186/2051-1426-2-S3-P85

Ejemplares similares